Skip to main content
OpenTrials
Completed

NCT Number: NCT06612463

Caffeine Supplementation on Movement Patterns and Reactive Agility in Rugby Sevens Matches

Caffeine is widely used by rugby players for its performance-enhancing effects. The main questions it aims to answer are: (1) the impact of caffeine supplementation on various performance metrics, including distance covered at different speeds, acceleration, deceleration, collisions, and repeated high-intensity efforts; and (2) reactive agility, across four matches over two consecutive days in collegiate male rugby sevens players.A position-matched, double-blind, randomized crossover design was employed, with six male collegiate rugby players (mean height: 1.78 ± 0.09 m, mean weight: 81.3 ± 9.2 kg) participating in two trials. Each trial consisted of a two-day tournament, with two matches per day. Movement was monitored using global positioning system units.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Exercise Behavior Motor Activity

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Early Phase 1

Primary location

National Taiwan University of Sport

Taichung, 404, Taiwan

About this study

This study employed a position-matched, double-blind, randomized crossover design. Pairs of participants with similar playing positions, specifically forwards or backs/scrum halves, were randomly assigned to either the caffeine or placebo trial. Each trial comprised a two-day rugby sevens tournament, with participants playing two matches per day. Following a 13-day washout period, participants switched to the alternate trial. Both the participants and the research personnel were blinded to the supplementation condition throughout the study period, with the assignment of supplements disclosed to research personnel only after all data analyses were completed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have undergone regular rugby training for at least three years
  • Member of a Division I university rugby team

Exclusion criteria

  • Musculoskeletal injury within one month prior to the study
  • Presence of major cardiovascular diseases
  • Presence of major metabolic diseases

Treatment and study plan

Caffeine 6mg/kg

Dietary Supplement

In the caffeine trial, participants ingested a capsule containing 3 mg/kg caffeine 60 min prior to each rugby sevens match. There was 2 matches per day. So the total dosage is 6 mg/kg/ day

Placebo

Dietary Supplement

In the placebo trial, participants ingested a capsule containing starch 60 min before each rugby sevens match. There were 2 matches per day

Primary outcomes

  1. Total Distance and Distance Covered in Speed Zones

    Time frame: Each trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

    This variable was measured with wearable global positioning system device during rugby sevens matches. Speed is divided into six zones: standing and walking (0-6 km/h), jogging (6-12 km/h), cruising (12-14 km/h), striding (14-18 km/h), high-intensity running (18-20 km/h), and sprinting (> 20 km/h). The distance covered in each speed zone and the total distance covered were recorded.

  2. Acceleration and Deceleration

    Time frame: Each trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

    This variable was measured with wearable global positioning system device during rugby sevens matches. For an activity to be included in the analysis, the movement speed must exceed 5 km/h, and the acceleration must be greater than 2 m/s² or the deceleration must be less than -2 m/s², sustained for more than 0.9 s. If the interval between two movements is less than 1 s, the subsequent movement will be combined with the previous one for analysis. The frequency and distance covered during these acceleration and deceleration phases were recorded.

  3. collision

    Time frame: Each trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

    This variable was measured with wearable global positioning system device during rugby sevens matches. Collision is defined as the number of times a participant accumulates 0.5 s standing after body contact resulting in a fall. Specific collision events include rucks, tackles, and instances where a player falls after contact

  4. Repeated High-Intensity Effort

    Time frame: Each trial contained 2 days, with 2 matches on each day. Each participant completed 2 trials

    This variable was measured with wearable global positioning system device during rugby sevens matches. A repeated high-intensity effort is defined as the completion of three or more high-intensity actions in succession, with rest periods of no more than 21 s between each action. The criteria for high-intensity actions include a movement speed of at least 14 km/h, an acceleration of at least 2 m/s², and a deceleration of at least -2 m/s²

  5. Reactive Agility

    Time frame: Each trial contained 2 days, with 2 matches on each day. Reactive agility was measured before each match. Each participant completed 2 trials

    The participants sprinted with the ball, passing through a light gate, after which an indicator light immediately displayed a left or right direction. The participants had to respond by changing direction according to the indicator and continue moving until they passed the second light gate positioned 1.5 m away from the indicator. The fastest time from two attempts was used for analysis.

Sponsors and collaborators

Lead sponsor

National Taiwan Sport University

Other

Registry information

Official study title

Effect of Caffeine Supplementation on Movement Patterns and Reactive Agility in Rugby Sevens Matches

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Sep 25, 2024
Registry last updated
Oct 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.